<SEC-DOCUMENT>0001437749-17-012893.txt : 20170721
<SEC-HEADER>0001437749-17-012893.hdr.sgml : 20170721
<ACCEPTANCE-DATETIME>20170721080115
ACCESSION NUMBER:		0001437749-17-012893
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20170721
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170721
DATE AS OF CHANGE:		20170721

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO KEY INTERNATIONAL INC
		CENTRAL INDEX KEY:			0001019034
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER COMMUNICATIONS EQUIPMENT [3576]
		IRS NUMBER:				411761861
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13463
		FILM NUMBER:		17975494

	BUSINESS ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING A, SUITE E
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719
		BUSINESS PHONE:		7323591100

	MAIL ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING A, SUITE E
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SAC TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19961115
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bkyi20170720_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD><TITLE>bkyi20170720_8k.htm</TITLE>
<!-- Created by RDG HTML Converter -->
</HEAD>
<BODY style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; MARGIN-LEFT: 10px; MARGIN-RIGHT: 10px">
<P id=PARA1 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 16pt; FONT-FAMILY: Times New Roman, Times, serif"><B>UNITED STATES </B></FONT></P>
<P id=PARA2 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 16pt; FONT-FAMILY: Times New Roman, Times, serif"><B>SECURITIES AND EXCHANGE COMMISSION</B></FONT></P>
<P id=PARA3 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Washington, D.C. 20549</B></FONT></P>
<P id=PARA4 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>_________________________</B></FONT></P>
<P id=PARA5 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>&nbsp;</B></FONT></P>
<P id=PARA6 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 16pt; FONT-FAMILY: Times New Roman, Times, serif"><B>FORM 8-K</B></FONT></P>
<P id=PARA7 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>&nbsp;</B></FONT></P>
<P id=PARA8 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif"><B>CURRENT REPORT </B></FONT></P>
<P id=PARA9 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B> </B></FONT></P>
<P id=PARA10 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA11 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Date of Report (Date of earliest event reported): July 21, 2017 </FONT></P>
<P id=PARA12 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA13 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif"><B>BIO-KEY INTERNATIONAL, INC.</B></FONT></P>
<P id=PARA14 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(Exact name of registrant as specified in its charter) </FONT></P>
<P id=PARA15 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=TBL22  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 33%; VERTICAL-ALIGN: top">
<P id=PARA16 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Delaware</B></FONT></P></TD>
<TD style="WIDTH: 33%; VERTICAL-ALIGN: top">
<P id=PARA17 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>001-13463</B></FONT></P></TD>
<TD style="WIDTH: 33%; VERTICAL-ALIGN: top">
<P id=PARA18 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>41-1741861</B></FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 33%; VERTICAL-ALIGN: top">
<P id=PARA19 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(State or other jurisdiction of incorporation)</FONT></P></TD>
<TD style="WIDTH: 33%; VERTICAL-ALIGN: top">
<P id=PARA20 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(Commission File Number)</FONT></P></TD>
<TD style="WIDTH: 33%; VERTICAL-ALIGN: top">
<P id=PARA21 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(I.R.S. Employer Identification No.)</FONT></P></TD></TR></TABLE>
<P id=PARA23 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA24 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">3349 Highway 138, Building A, Suite E</FONT></P>
<P id=PARA25 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Wall, NJ 07719 </FONT></P>
<P id=PARA26 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(Address of principal executive offices) (Zip Code) </FONT></P>
<P id=PARA27 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA28 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(732) 359-1100</FONT></P>
<P id=PARA29 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(Registrant's telephone number, including area code) </FONT></P>
<P id=PARA30 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA31 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<U>see</U><I> </I>General Instruction A.2. below):</FONT></P>
<P id=PARA32 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA33 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9744;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></P>
<P id=PARA34 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA35 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9744;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></P>
<P id=PARA36 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA37 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9744;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></P>
<P id=PARA38 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA39 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9744;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></P>
<P id=PARA40.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P>
<P id=PARA76 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.</FONT></P>
<P id=PARA77 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA78 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Emerging growth company&nbsp; </FONT>&#9744;</P>
<P id=PARA79 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA80 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp; </FONT>&#9744;</P>
<P style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<DIV id=PGBK40  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR40  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM40  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR40  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA40.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT></P>
<TABLE id=TBL43  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 63pt; VERTICAL-ALIGN: top">
<P id=PARA81><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Item </B><B>8</B><B>.01</FONT></B></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA82><B><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Other Events</B><B>.</B></P></FONT></B></TD></TR></TABLE>
<P id=PARA44 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA45 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On July 21, 2017, BIO-key International, Inc. (the &#8220;Company&#8221;) issued a press release announcing that its common stock had been approved for listing on The NASDAQ Capital Market, and that it expects to commence trading under its current trading symbol &#8220;BKYI&#8221; on or about July 25, 2017. A copy of the press release is attached as Exhibit 99.1 to this report and is incorporated herein by reference. </FONT></P>
<P id=PARA46 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=TBL47  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 63pt; VERTICAL-ALIGN: top">
<P id=PARA83><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Item 9.01</FONT></B></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA84><B><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Financial Statements and Exhibits</P></FONT></B></TD></TR></TABLE>
<P id=PARA48 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>&nbsp;</B></FONT></P>
<TABLE id=TBL49  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA85><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(d)</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA86><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exhibits</P></FONT></TD></TR></TABLE>
<P id=PARA50 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB52  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA53 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">99.1</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA54 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Press Release of BIO-key International, Inc. dated July 21, 2017</FONT></P></TD></TR></TABLE>
<P id=PARA55 style="TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT></P>
<DIV id=PGBK56  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR56  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM56  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR56  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA56.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P>
<P id=PARA58 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>SIGNATURES</B></FONT></P>
<P id=PARA59 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>&nbsp;</B></FONT></P>
<P id=PARA60 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</FONT></P>
<P id=PARA61 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=TBL87  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD vAlign=top width="50%">
<P id=PARA87.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="38%" colSpan=2>
<P id=PARA87.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BIO-Key International, Inc.</FONT></P></TD>
<TD vAlign=top width="12%">
<P id=PARA87.3 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR>
<TR>
<TD vAlign=top width="50%">
<P id=PARA87.4 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="3%">
<P id=PARA87.5 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="35%">
<P id=PARA87.6 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="12%">
<P id=PARA87.7 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR>
<TR>
<TD vAlign=top width="50%">
<P id=PARA87.8 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="3%">
<P id=PARA87.9 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=bottom width="35%" noWrap align=left>
<P id=PARA87.10 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="12%">
<P id=PARA87.11 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR>
<TR>
<TD style="TEXT-ALIGN: left" vAlign=top width="50%" align=left>
<P id=PARA87.12 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Date:&nbsp; July 21, 2017</FONT></P></TD>
<TD style="TEXT-ALIGN: left" vAlign=top width="3%">
<P id=PARA87.13 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">By: </FONT></P></TD>
<TD style="BORDER-BOTTOM: #000000 1px solid" vAlign=top width="35%" noWrap align=left>
<P id=PARA87.14 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">/s/&nbsp;</FONT><I>Michael W. DePasquale</I></P></TD>
<TD vAlign=top width="12%">
<P id=PARA87.15 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR>
<TR>
<TD vAlign=top width="50%">
<P id=PARA87.16 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="3%">
<P id=PARA87.17 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="35%">
<P id=PARA87.18 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Michael W. DePasquale</FONT></P></TD>
<TD vAlign=top width="12%">
<P id=PARA87.19 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR>
<TR>
<TD vAlign=top width="50%">
<P id=PARA87.20 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="3%">
<P id=PARA87.21 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="35%">
<P id=PARA87.22 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Chief Executive Officer</FONT></P></TD>
<TD vAlign=top width="12%">
<P id=PARA87.23 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR></TABLE></BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML><HEAD><TITLE>ex99-1.htm</TITLE>
<!-- Created by RDG HTML Converter -->
</HEAD>
<BODY style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; MARGIN-LEFT: 10px; MARGIN-RIGHT: 10px">
<P id=PARA82 style="MARGIN-BOTTOM: 0px; TEXT-ALIGN: right; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Exhibit 99.1</B></FONT></P>
<P id=PARA83 style="MARGIN-BOTTOM: 0px; TEXT-ALIGN: left; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp;</P>
<TABLE  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0>

<TR>
<TD style="WIDTH: 30%"><IMG src="biokey.jpg" width=211 height=55></TD>
<TD style="WIDTH: 70%">
<P id=PARA71 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT>&nbsp;</P>
<P style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Nasdaq Approves Listing of </B><B>Biometric Software&nbsp;and Hardware Solutions Provider, </B><B>BIO-key</B><B> International, Starting Tuesday, July 25, 2017</B></FONT></P></TD></TR></TABLE>
<P id=PARA40 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT>&nbsp;</P>
<P id=PARA45 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Wall, NJ, July 21, 2017</B> - BIO-key International, Inc. (OTCQB: BKYI), a trusted provider of enterprise and consumer biometric software and hardware solutions for strong and convenient user authentication, announced today that its Common Stock has been approved for listing on the Nasdaq Capital Market, effective with the start of trading on Tuesday, July 25, 2017. BIO-key&#8217;s shares will continue to trade under the symbol <B>BKYI</B>.</FONT></P>
<P id=PARA46 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA47 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Michael DePasquale, Chairman &amp; CEO of BIO-key, commented, "Our Nasdaq listing is a significant milestone for BIO-key and our shareholders, that underscores our ramping sales momentum so far this year. We continue to see growing interest in the efficiency, cost benefits and enhanced security of our biometric solutions. This trend is supported by the growing prevalence of fingerprint biometric solutions on mobile devices as well as the recognition that conventional password and PIN authentication is fundamentally broken.</FONT></P>
<P id=PARA48 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA49 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;Innovation is also playing a pivotal role in expanding BIO-key&#8217;s business potential. We continue to develop new technology to solve pressing, large-scale cybersecurity and authentication challenges as well as consumer-facing products that leverage our core biometric expertise. "</FONT></P>
<P id=PARA50 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>&nbsp;</B></FONT></P>
<P id=PARA51 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Mr. DePasquale added, &#8220;In addition to providing a range of benefits to our shareholders, we believe listing on Nasdaq will also support our sales and marketing momentum by raising the visibility of our brand and authentication solutions before prospective customers, partners and the media.&#8221;</FONT></P>
<P id=PARA52 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA53 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">BIO-key was advised by Maxim Group LLC and Donohoe Advisory Associates LLC in its Nasdaq listing process. </FONT></P>
<P id=PARA54 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P>
<P id=PARA55 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>About BIO-key International, Inc. (</B>www.bio-key.com<B>)</B></FONT></P>
<P id=PARA57 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">BIO-key is revolutionizing authentication with biometric solutions that enable convenient and secure access to information and secure high-stakes transactions. We offer alternatives to passwords, PINs, tokens and cards to make it easy for enterprises and consumers to secure their devices as well as information in the cloud. Our premium finger scanning devices, including SideSwipe, </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">SideTouch, </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">EcoID </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">as well as SidePass, offer market-leading quality, performance and price. BIO-key is also bringing the power and ease of use of biometric technology to its recently launched TouchLock line of biometric and Bluetooth enabled padlocks &#8211; providing even more ways to BIO-key your world!</FONT></P>
<P id=PARA58 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA59 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>BIO-key Safe Harbor Statement</B></FONT></P>
<P id=PARA60 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Certain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, market acceptance of biometric solutions generally and our specific offerings, our ability to expand into the Asian market, the impact on our business of the recent financial crisis in the global capital markets, negative global economic trends and our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2016 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made.</FONT></P>
<P id=PARA61 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0>

<TR>
<TD style="WIDTH: 17%">
<P id=PARA74 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><B>Facebook &#8211; Corporate:</B></P></TD>
<TD style="WIDTH: 83%">
<P id=PARA75 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">BIO-key International</P></TD></TR>
<TR>
<TD style="WIDTH: 17%">
<P id=PARA76 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><B>Twitter &#8211; Corporate:&nbsp;</B></P></TD>
<TD style="WIDTH: 83%">
<P id=PARA77 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">@BIOkeyIntl</P></TD></TR>
<TR>
<TD style="WIDTH: 17%">
<P id=PARA78 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><B>Twitter &#8211; Investors:</B>&nbsp;</P></TD>
<TD style="WIDTH: 83%">
<P id=PARA79 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">@BIO_keyIR</P></TD></TR></TABLE>
<P id=PARA62 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P>
<P id=PARA66 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Investor &amp; Media Contacts: </B></FONT></P>
<P id=PARA67 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">David Collins; William Jones; Tanya Kamatu</FONT></P>
<P id=PARA68 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Catalyst Global<BR>212-924- 9800 </FONT></P>
<P style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>bkyi@catalyst-ir.com</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>biokey.jpg
<TEXT>
begin 644 biokey.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  W -,# 2(  A$! Q$!_\0
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MD94C0%F9C@*!U)-?G-_P4/\ ^#A?P+^SI<WGA+X30VOQ*\=+N@:ZA<OHVFR
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MHKBOV</C9IG[27[/_@KX@Z,ZOI?C30[/6K;:<[%GA63;]5W8/N#7YX?MD?\
M!0OXQ_&#_@NA\,OV6_@7XK7PYH'AVSCUGXEWT6GVMXP@.VXDAW2H_ED6_DHI
M7!\R]7/W10!^HE%>$_M;>)O$_A/XC?#]]$\2>(])TR]DU)M6M-/M+::*>*UT
MVYNDRTD$C(S31Q+PPRI*@9.:\=_90_:A^,?Q$^+WPP\,>*I+A(M#@O\ 2_&]
MXVA"VC\0ZB]D+VSEA.W$426IA=O+(!DN?+/,9% 'VQ1110!X;_P46_8OTO\
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M^:/=K+Q';^*?!T6KZ'=6NIVFHV8O-/N;>02PW:.F^)T8<,K J01P017\\/\
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M?^"27B_]E6'Q#?\ BC1_$-AJD<6IZC D,D5Q=,TL,FQ,@>5-Y;CW3->&R_\
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MQ==Z]KOA\7FL7RP)-=K>3PR$06]Y;Q;3&Z[2L6H7:@K@_OB>H4@HH YO2_\
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
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
